Are you a medically qualified Clinical Oncology trainee with an interest in research and advanced radiotherapy technologies? Do you want to further your career in one of the UK’s leading research intensive Universities?
In your role as Clinical Research Fellow you will have a key role in supporting the research activity of the UK Advanced Radiotherapy Technologies Network (ART-NET) group.
A CRUK Network Accelerator Award has established this research network across 5 UK radiotherapy sites including University of Leeds/Leeds Teaching Hospitals NHS Trust. The aim of the award is to develop further research and collaboration in implementation of Stereotactic Ablative Body Radiotherapy (SABR), MR Linac and Proton Beam therapy. ART-NET comprises 7 workstreams, and you will work on two of the streams Leeds are co-leading (MR based radiotherapy planning and Motion Management for SABR).
In this exciting opportunity you will be supported to study for a PhD whilst undertaking the role. You will be closely supervised in all aspects of the research and must be capable of interdisciplinary working across radiotherapy, medical physics and clinical trials. You must hold a medical qualification and have completed or be undertaking clinical oncology specialist training.
To explore the post further or for any enquiries you may have, please contact:
Dr Ann Henry, Associate Professor in Clinical Oncology
Tel: +44 (0)113 206 7630, email: a.henry@leeds.ac.uk
Interviews are anticipated to take place on 27 or 28 November 2017
Further Information
The University of Leeds is committed to providing equal opportunities for all and offers a range of family friendly policies. The University is a charter member of Athena SWAN and holds the Bronze award. The School of Medicine gained the Silver award in 2016. We are committed to being an inclusive medical school that values all staff, and we are happy to consider job share applications and requests for flexible working arrangements from our employees.
Closing Date: 31 Oct 2017
Category: Clinical
